gmc-252-l-lysine
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2012 (NCT02686281)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gmc-252-l-lysine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02744820 | Phase 1 | Apr 1, 2016 | Genmedica Therapeutics S.L., Simbec-Orion |
| NCT02686281 | Phase 1 | Sep 1, 2012 | Genmedica Therapeutics S.L., Simbec-Orion |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genmedica Therapeutics S.L. | For profit | 2 | 2 | 1 | 2012 |
| Simbec-Orion | For profit | 2 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1